Cargando…
Human Monoclonal Antibodies against Glucagon Receptor Improve Glucose Homeostasis by Suppression of Hepatic Glucose Output in Diet-Induced Obese Mice
AIM: Glucagon is an essential regulator of hepatic glucose production (HGP), which provides an alternative therapeutic target for managing type 2 diabetes with glucagon antagonists. We studied the effect of a novel human monoclonal antibody against glucagon receptor (GCGR), NPB112, on glucose homeos...
Autores principales: | Kim, Wook-Dong, Lee, Yong-ho, Kim, Min-Hee, Jung, Sun-Young, Son, Woo-Chan, Yoon, Seon-Joo, Lee, Byung-Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513295/ https://www.ncbi.nlm.nih.gov/pubmed/23226550 http://dx.doi.org/10.1371/journal.pone.0050954 |
Ejemplares similares
-
Intra-islet glucagon secretion and action in the regulation of glucose homeostasis
por: Wang, Qinghua, et al.
Publicado: (2013) -
Ghrelin and glucagon-like peptide-1 according to body adiposity and glucose homeostasis
por: Lopes, Karynne Grutter, et al.
Publicado: (2023) -
Time-dependent effects of endogenous hyperglucagonemia on glucose homeostasis and hepatic glucagon action
por: Lubaczeuski, Camila, et al.
Publicado: (2023) -
α-cell glucokinase suppresses glucose-regulated glucagon secretion
por: Basco, Davide, et al.
Publicado: (2018) -
Arcuate Glucagon-Like Peptide 1 Receptors Regulate Glucose Homeostasis but Not Food Intake
por: Sandoval, Darleen A., et al.
Publicado: (2008)